Literature DB >> 35677499

Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.

Anshuman Elhence1, Bhavik Bansal2, Hardik Gupta2, Abhinav Anand2, Thakur P Singh1, Amit Goel1.   

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) contributes to a large proportion of liver disease burden in the world. Several groups have studied the prevalence of NAFLD in the Indian population. Aim: A systematic review of the published literature and meta-analysis was carried out to estimate the prevalence of NAFLD in the Indian population.
Methods: English language literature published until April 2021 was searched from electronic databases. Original data published in any form which had reported NAFLD prevalence in the Indian population were included. The subgroup analysis of prevalence was done based on the age (adults or children) and risk category, i.e., average-risk group (community population, participants of control arm, unselected participants, hypothyroidic individuals, athletes, aviation crew, and army personnel) and high-risk group (obesity or overweight, diabetes mellitus, coronary artery disease, etc.). The prevalence estimates were pooled using the random-effects model. Heterogeneity was assessed with I2.
Results: Sixty-two datasets (children 8 and adults 54) from 50 studies were included. The pooled prevalence of NAFLD was estimated from 2903 children and 23,581 adult participants. Among adults, the estimated pooled prevalence was 38.6% (95% CI 32-45.5). The NAFLD prevalence in average-risk and high-risk subgroups was estimated to be 28.1% (95% CI 20.8-36) and 52.8% (95% CI 46.5-59.1), respectively. The estimated NAFLD prevalence was higher in hospital-based data (40.8% [95% CI 32.6-49.3%]) than community-based data (28.2% [95% CI 16.9-41%]). Among children, the estimated pooled prevalence was 35.4% (95% CI 18.2-54.7). The prevalence among non-obese and obese children was 12.4 (95% CI 4.4-23.5) and 63.4 (95% CI 59.4-67.3), respectively.
Conclusion: Available data suggest that approximately one in three adults or children have NAFLD in India.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; BMI, Body mass index; CAD, Coronary artery disease; CI, Confidence interval; DM, Diabetes mellitus; GBD, Global burden of disease; GDM, Gestational diabetes mellitus; GDP, Gross domestic product; HC, Healthy control; IGT, Impaired glucose tolerance; NAFLD, Non-alcoholic fatty liver disease; NASH, Non-alcoholic steatohepatitis; NPCDCS, National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke; OSA, Obstructive sleep apnea; PCOS, Polycystic ovarian syndrome; UT, Union Territories; diabetes mellitus; fatty liver; metabolic syndrome; obesity; steatohepatitis

Year:  2021        PMID: 35677499      PMCID: PMC9168741          DOI: 10.1016/j.jceh.2021.11.010

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  66 in total

1.  Central obesity but not generalised obesity (body mass index) predicts high prevalence of fatty liver (NRFLD), in recently detected untreated, IGT and type 2 diabetes Indian subjects.

Authors:  Debmalya Sanyal; Pradip Mukhopadhyay; Kaushik Pandit; Satinath Mukhopadhyay; Subhankar Chowdhury
Journal:  J Indian Med Assoc       Date:  2009-11

2.  Prediction of nonalcoholic fatty liver in prospective liver donors.

Authors:  Narendra S Choudhary; Neeraj Saraf; Sanjiv Saigal; Ajay Duseja; Dheeraj Gautam; Lipika Lipi; Amit Rastogi; Sanjay Goja; Prashant Bhangui; Sumana K Ramchandra; Yalakanti Raghavendra Babu; Arvinder S Soin
Journal:  Clin Transplant       Date:  2017-02-13       Impact factor: 2.863

3.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

4.  Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.

Authors:  Kausik Das; Kshaunish Das; Partha S Mukherjee; Alip Ghosh; Sumantra Ghosh; Asit R Mridha; Tapan Dhibar; Bhaskar Bhattacharya; Dilip Bhattacharya; Byomkesh Manna; Gopal K Dhali; Amal Santra; Abhijit Chowdhury
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

5.  Non-Alcoholic Fatty Liver Disease (NAFLD) - Is it an Emerging Risk Factor for Coronary Artery Disease?: Preliminary study in a local Indian population.

Authors:  Manopriya Thiruvagounder; Shaheen Khan; Dhastagir S Sheriff
Journal:  Sultan Qaboos Univ Med J       Date:  2010-07-19

6.  Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Authors:  M Prashanth; H K Ganesh; M V Vima; M John; T Bandgar; Shashank R Joshi; S R Shah; P M Rathi; A S Joshi; Hemangini Thakkar; P S Menon; N S Shah
Journal:  J Assoc Physicians India       Date:  2009-03

Review 7.  The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.

Authors:  Emma L Anderson; Laura D Howe; Hayley E Jones; Julian P T Higgins; Debbie A Lawlor; Abigail Fraser
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

8.  Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents.

Authors:  Vandana Jain; Manisha Jana; Babita Upadhyay; Nayeem Ahmad; Oshima Jain; Ashish Datt Upadhyay; Lakshmy Ramakrishnan; Naval K Vikram
Journal:  Indian J Med Res       Date:  2018-09       Impact factor: 2.375

9.  Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India.

Authors:  Surya Prakash Bhatt; Randeep Guleria; Naval K Vikram; S Vivekanandhan; Yogendra Singh; A K Gupta
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.